Latest Articles

Genetic Testing Can Predict Metastasis and Death in Prostate Cancer
BY SILAS INMAN
The Decipher test can be used to predict death and metastases in some patients with prostate cancer, according to findings that were recently presented.
Timing is Key: Smoking Cessation Successful When Tele-Counseling and Lung Cancer Screening Are Paired
BY ALLIE CASEY
Telephone-based smoking cessation counseling helped patients quit smoking, according to a recent study.
Lynparza Improves Survival in Breast Cancer, According to Recent Study
BY JASON M. BRODERICK
In a recent phase 3 trial, Lynparza improved progression-free survival in patients with BRCA-positive, HER2-negative breast cancer. 
Agent Shows Promise and Safety in Small Cell Lung Cancer
BY ALLIE CASEY
Rova-T proved to be safe and effective in patients with small cell lung cancer according to a recent study.
Blincyto Seeks FDA Approval for Leukemia Treatment
BY JASON M. BRODERICK
A supplemental biologics license application was filed for Blincyto to be approved for certain patients with ALL.
Study Supports Novel Therapy for Low-Risk Prostate Cancer
BY ANGELICA WELCH
Padeliporfin vascular-targeted photodynamic therapy may be a promising option for men with low-risk prostate cancer, according to the results of a recent study.
Another Year of Lung Cancer Advancements Expected in 2017
BY GINA COLUMBUS
2016 was an exciting year for non-small cell lung cancer, and more advances are expected for 2017. 
Entrectinib Clinical Trials: Changing the Game with Genetic Testing
BY ALLIE CASEY
STARTRK-2 trial is a currently enrolling trial to test the efficacy and safety of the agent entrectinib which targets 5 abnormalities across a number of cancer sites. 
Novel Approach Aims at Improving Survival in Laryngeal Cancer
BY DANIELLE BUCCO
Researchers at the University of Michigan are hoping to improve the survival rates for laryngeal cancer.